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Abstract
Clusters comprise of a particular set of ingredients, which includes researchers,
entrepreneurs, venture capitalists, well-trained and educated workers, and specialized
professional services. The importance of each ingredient is undeniable, yet the proximity
to research centers and institutions is perhaps the most critical element of success for
technology clusters. This thesis focuses on the Massachusetts Institute of Technology
(MIT), and examines its role in the development of the biomedical industry cluster in
Cambridge, Massachusetts.
However, while the important role that academic institutions play in the process of
transforming science to marketable technology is acknowledged, the question of who are
the actual researchers most intimately involved in this process remains unanswered.
Drawing on quantitative data, we show that the majority of commercially related research
work is performed by a small fraction of the researchers, and this group is heterogeneous
in characteristics. Moreover, through a novel way of examining publication data, we also
show that the commercial productivity of each researcher is positively related to the
researcher's relative level of applied science research.
Over the past two years, Singapore has been among the most aggressive of the East Asian
countries in pursuing the development of its biotechnology industry. By benchmarking
Singapore against MIT, we recommend that Singapore raise its level of applied science
research, to improve the integration of academic research into the marketplace.
Thesis Supervisor: Fiona E. Murray
Title: Assistant Professor of Management of Technology, Innovation and
Entrepreneurship
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I Introduction
Clusters are groups of inter-related industries. They have two key elements. Firstly, firms
in the cluster must be linked. Secondly, groups of inter-linked companies must be located
within close proximity of one another. Professor Michael Porter refers to clusters as
"Geographic concentrations of interconnected companies, specialized suppliers, service
providers, firms in related industries, and associated institutions (for example
universities, standards agencies, and trade associations) in particular fields that compete
but also co-operate." (Porter, 1998) The links between firms are both vertical, through
buying and selling chains; and horizontal, through complimentary products and services,
the use of similar specialized inputs, technologies or institutions, and other linkages.
Most of these linkages involve social relationships or networks that produce mutual
benefits for the firms involved. Co-location encourages the formation of contacts between
firms and can enhance the value creating benefits arising from networks. The geographic
area covered by clusters can vary dramatically. There may even be multiple operating
scales, with regional, national and even international dimensions to some clusters.
Clusters comprise a set of ingredients that includes researchers, entrepreneurs, venture
capitalists, well-trained and educated workers, and specialized professional services. The
importance of each ingredient is undeniable, yet the proximity to research centers and
institutions is perhaps the most critical element of success for technology clusters. This
thesis focuses on the Massachusetts Institute of Technology (MIT), and examines its role
in the development of the biomedical industry cluster in Cambridge, Massachusetts.
Cambridge has emerged today as one of the most advanced centers in the United States
for biomedicine, and a large number of researchers and faculty members in MIT are
deeply involved in biomedical science research. This thesis examines the characteristics
of researchers in departments that have made a significant contribution to
commercialization in the life sciences. It examines what proportions of scientists are
commercially active and if they have specific identifiable characteristics. Lastly, the
thesis also addresses the extent to which commercial activity is a tradeoff or substitute for
basic research work.
However, while the important role that academic institutions play in the process of
transforming science to marketable technology is acknowledged, the identities of the
researchers who are most intimately involved in this process are largely unknown. Little
is known about the actual proportion of researchers involved in this aspect of research
work among the entire population. And little is known about the organizational
structures that would be most conducive towards the development and promotion of
commercial work. This thesis attempts to fill in these gaps, by examining MIT and its
faculty members' research work and developing quantifiable statistical measures. We
examine and study a total of 143 researchers, and associated with them, 776 patents and
5259 journal articles.
Over the past two years, Singapore has been among the most aggressive of the East Asian
countries in pursuing the development of its biotechnology industry. Last year,
Singapore's Economic Development Board (EDB) committed a total of S$2 billion
toward investment funds to help develop the country's R&D infrastructure, half of which
will be spent in the biotechnology and health sector. During the past few years, the
Singapore government has spent some $120 million on biotechnology investments
through existing funds.' The new initiatives are geared toward positioning Singapore as a
premier biomedical cluster in East Asia. This thesis will seek to address some of the key
policies that would be critical towards the development of such a cluster in Singapore, by
benchmarking Singapore against Cambridge/MIT.
1.1 Thesis Overview
Chapter 2 discusses some of the recent related work on cluster development, as well as
focusing on research conducted on development of biotechnology clusters. In addition,
the Chapter examines ideas behind innovation, knowledge flows and spillovers.
Chapter 3 describes in detail, the data employed in our analysis. In particular, the
Chapter focuses on the various measures of commercial productivity developed in the
'Singapore Economic Development Board has a SG$1 billion (US$588 million) investment fund
committed solely to biomedical sciences research and development.
course of research. The Chapter discusses in detail how the collection of the data as well
as the sources.
Chapter 4 builds on the previous chapter, and will describe the results from our research
into MIT and Singapore. It will present the key quantitative results derived from our
research. The Chapter goes into detail the results derived from applying these measures
in the analysis of the research activities of MIT and Singapore. This chapter will discuss
in detail data sets and sources collected, as well as highlight and describe the importance
of the different fields of the dataset. It will briefly describe the accuracy and validity of
the datasets.
Chapter 5 discusses the policy implications of the findings and suggests
recommendations. It will attempt to answer questions such as if Singapore's science
researcher recruitment policies are conducive to the overall cluster's development, and
make policy recommendations to increase the growth and development of the cluster. It
will serve as a conclusion to the thesis and suggest possible directions for future research.
1.2 Conceptual Framework
In this thesis, we begin to look at this issue by focusing on a select group of researchers,
draw from six departments at MIT, one of the nation's preeminent research institutions.
These researchers are selected based on their active work in the life sciences. Drawing on
comprehensive quantitative information about each faculty member's patenting and
publication behavior, we explore the distribution to which commercially related research
work is being conducted at MIT, and attempt to find characteristics that can distinguish
these researchers.
It is helpful to envision academic research and its interaction with industry along two
axes. We call the first axis Commercial Activity. This axis indicates how active a
researcher chooses to be in commercializing their research, as measured by his patenting
history. This has been the area that most current and past research has focused on.
However, there is a need to describe a second axis. We call it Commercial Opportunity.
This axis measures how active the researcher is involved in commercially applicable
research.
The difference between the two concepts is subtle but important. While Commercial
Activity is concerned with ostensible measures such as patenting histories, Commercial
Opportunity is an indication of the area of research the researcher is involved in. Figure
1 describes the two dimensional model that we are proposing here.
Commercial
Activity
X
Commercial Opportunity
Figure 1: Commercial Activity versus Commercial Opportunity
Previous studies have concentrated on measuring how active researchers are
commercially, based on their patenting and patent citation histories. This is represented
by representation of faculty members along the vertical axis (Commercial Activity).
However, this does not represent the full picture. A researcher could be deeply involved
in research with high commercial potential but choose not to patent it. In other words, his
research work has high Commercial Opportunity but he has low Commercial Activity.
On the graph, he would be at point X. It is unclear if researchers are commercially active
due to their explicit choice of research materials. On the other hand, a researcher could be
engaged in commercially relevant research but choose not to patent, preferring to have
the knowledge in the public domain through publication only (or perhaps engaging only
in consulting etc. which is unobservable with the measures we are using)
Past studies have failed to capture this dimension. This is in part due to sheer difficulty;
beyond using patent data, it is hard to ascertain the commercial potential of the research
work. In this thesis, via a novel method of studying publication data, we will present a
set of quantitative measures that will allow us to capture this dimension.
Collectively, what we seek to achieve from our research is to paint a definitive profile of
the researchers who are commercially most active. We seek to understand if they can be
distinguished by a set of characteristics. We want to understand if their commercial
activities are affected by other variables, such as their publishing activity. And very
importantly, we want to understand if their commercial activity is related to their
commercial opportunity. In other words, we like to know if researchers are commercially
active due to a conscious choice in their research material, thereby giving them the
opportunity to be commercially active. The alternative scenario is plausible as well, that
there could exist researchers who are engaged in research with high commercial
potential, but just choose not to patent it. By representing researchers on the graph via
the two axes, we seek to paint an accurate picture that best model academic research.
Our study builds most strongly work by Zucker and Darby and their collaborators
(Zucker, Darby and Armstrong, 1998; Zucker, Darby and Brewer, 1998), who have
demonstrated the importance of geographic proximity, research collaborations, and
personal relationships in the transfer of knowledge, as well as Henderson and Agrawal
and their collaborators (Henderson and Agrawal, 2001; Henderson, Trajtenberg and Jaffe,
1998; Henderson, Trajtenberg and Jaffe, 1996) for their work on knowledge transfers
from academic settings to industry, as evidenced by patent citations.
In summary, these are the salient questions we seek to answer:
* Who are the MIT researchers most active in commercial research?
* Are these researchers different from other researchers? If so, how are they
different?
* How does Singapore compare with MIT?
" What can Singapore learn from MIT?
2 Related Work
This thesis builds upon several well researched areas. In particular, we focus on the
concepts of cluster formation, measurements of innovation, as well as the overarching
issue of academia and industry interaction.
2.1 Concept of Cluster
The cluster concept was originally developed in 1990 by Harvard Business School
(Cambridge, MA, USA) professor Michael Porter in a book called The Competitive
Advantage of Nations, which describes clusters as the geographic concentrations of
interconnected companies, specialized suppliers, service providers, firms in related
industries and associated institutions in particular fields that compete but also cooperate.
Today's economic map of the world is dominated by clusters or critical masses-in one
place -of unusual competitive success in particular fields. Clusters are a striking feature
of virtually every national, regional, state, and even metropolitan economy, especially in
more economically advanced nations. Silicon Valley and Hollywood may be the world's
best-known clusters. Clusters are not unique, however; they are highly typical and therein
lies a paradox: the enduring competitive advantages in a global economy lie increasingly
in local things - knowledge, relationships, motivation - that distant rivals cannot match.
Clusters are geographic concentrations of interconnected companies and institutions in a
particular field. Clusters encompass an array of linked industries and other entities
important to competition. They include, for example, suppliers of specialized inputs such
as components, machinery, and services, and providers of specialized infrastructure.
Clusters also often extend downstream to channels and customers and laterally to
manufacturers of complementary products and to companies in industries related by
skills, technologies, or common inputs. Finally, many clusters include governmental and
other institutions - such as universities, standards-setting agencies, think tanks, vocational
training providers, and trade associations - that provide specialized training, education,
information, research, and technical support.
Clusters represent a kind of new spatial organizational form in between arm's-length
markets on the one hand and hierarchies, or vertical integration, on the other. A cluster,
then, is an alternative way of organizing the value chain. Compared with market
transactions among dispersed and random buyers and sellers, the proximity of companies
and institutions in one location-and the repeated exchanges among them fosters better
coordination and trust. Thus clusters mitigate the problems inherent in arm's-length
relationships without imposing the inflexibilities of vertical integration or the
management challenges of creating and maintaining formal linkages such as networks,
alliances, and partnerships. A cluster of independent and informally linked companies
and institutions represents a robust organizational form that offers advantages in
efficiency, effectiveness, and flexibility.
Previous studies and economic analysis demonstrate that clusters can raise innovation
and productivity in a number of ways. Companies benefit from sharing knowledge with
academic institutions about best practice and reduce costs by jointly sourcing services
and suppliers. Frequent interactions between industry and academic institutions facilitate
formal and informal knowledge transfer and encourage the formation and efficiency of
collaboration between institutions with complementary assets and skills. There is also the
"general importance of being in the midst of the buzz". (Krugman, P, 1998) The critical
mass effect attracts further companies, investors, services, and suppliers into the cluster,
as well as creating a pool of skilled labor.
2.2 Academic Research Underlying Industrial Innovation
In recent years there have been great interest in the process by which firms benefit from
externally performed R&D, and the extent and importance of such spillovers. In
particular, Jaffe, Von Hippel and others have shown that technological changes in several
key sectors of the economy have been influenced by academic research. (Jaffe, 1988;
Von Hippel, 1989)
Beyond technological changes, research has also shown that research in universities
contribute to the economy. About 11% of all new product innovations and 9% of all
process innovations can be directly attributed to academic research in universities.
(Mansfield, 1995) This is especially relevant in high tech industries such as the
biotechnology industry, where an even greater proportion of total research takes place in
academic settings. In summary, universities represent a key component of a cluster,
especially critical to knowledge formation and dispersal.
While there is a widespread belief that publicly funded research conducted at universities
has a significant impact on the rate of economic growth, estimating the magnitude and
describing the nature of this impact remains extremely difficult. Recent quantitative work
in the area has focused particularly on patents as a measure of university "output" (Jaffe,
1989; Henderson, Jaffe and Trajtenberg, 1998), on licenses and on the new firms created
by licenses (Gregorio and Shane, 2000; Jensen and Thursby, 1998; Thursby and Thursby,
2000), or on patents and licensing considered simultaneously (Mowery et al, 1998). As a
logical extension, patent citation data has been widely used in a variety of studies
concerning university innovation (Jaffe, Trajtenberg and Henderson, 1993; Jaffe, Fogarty
and Banks, 1998; Jaffe and Trajtenberg, 1996).
Patent and license data has become particularly important in this context for three
reasons. First, the patenting process requires that inventor names, dates, assignee
institutions, locations, and detailed descriptions of invention claims be recorded. Such
systematically recorded innovation-related details are very rare outside of patent records.
Second, innovations that are patented are expected, by definition, to be commercially
useful. Third, patenting data has recently become widely available in machine readable
form, and aggressive research programs, coupled with the generous efforts of AUTM
(The Association of University Technology Managers), has recently made much
university licensing data available.2 A focus on patents and licensing as an important
mechanism of knowledge transfer from universities to the private sector is thus
understandable.
2 The Association of University Technology Managers was founded in 2001 with the aim of promoting,
supporting and enhancing the global academic technology transfer profession through internal and external
education, training and communication. <http:// www.autm.net/index_ie.html>
However while the role of academic research is acknowledged, the characteristics of the
most active researchers in commercial life sciences research is largely unknown.
Henderson and Agrawal (Henderson and Agrawal, 2001) suggest based on qualitative
research work, that researchers largely do not embark on research agendas with either
patent or paper outcome in mind. However, their quantitative results suggest that there
exists a group of researchers who patent disproportionately more than their peers. While
these results provide us with some intriguing preliminary insights into entrepreneurial
faculty, as they authors point out, they raise as many questions as they answer. We still
need to understand who are these researchers and how are they different from the other
researchers.
3 Data and Methods
The heart of the thesis is an in-depth quantitative study of professors who are currently on
the faculty at MIT, who are most active in life sciences or biomedical sciences related
research. A total of 143 active full time faculty members are selected. Their affiliations
are spread across six departments, namely Biology, Biological Engineering, Chemistry,
Chemical Engineering, Whitehead Institute and Health Science and Technology (HST).
Some of them hold joint appointments with more than one department.
MIT was chosen as the focal university as it is one of the premier research institutions in
the United States. In 1998, MIT claimed almost 4% of all the patents given to American
universities and received over 1.5% of all federal funding for science and engineering at
universities and colleges in fiscal year 1999. 3 Beyond that, MIT has been very important
to the development of the biomedical hub in Cambridge, Massachusetts. Hence, a study
of MIT is likely to yield useful insights for aspiring clusters such as Singapore.
For Singapore, we chose 145 researchers who are based in Singapore. These researchers
are drawn from the 4 semi-autonomous institutions set up since 1998, with each
institution focusing on specific areas of the biomedical sciences.4 They are the Institute
of Cellular and Molecular Biology (IMCB), the Institute of Bioengineering and
Nanotechnology (IBN), the Genome Institute of Singapore (GIS), Institute of Chemical
and Engineering Sciences (ICES). These researchers were selected based on their
affiliation, as well as their research work, which are in the life sciences.
For our study, we employ three main classes of information:
* Patents
* Publications
* Other characteristics
3 NSF report: Federal Science and Engineering Support to Universities, Colleges, and Nonprofit
Institutions: Fiscal Year 1999.
4 The research institutes are semi-autonomous, with a central governing body called the Agency for
Science, Technology and Research (A*STAR)
o Tenured status
o Gender
o Scientific Advisory Board membership
Our research strategy is to first do a broad survey of the patent histories of all 143 MIT
faculty members, as a means to identify those who are the most commercially active. To
this end, we apply our set of quantitative methodologies to the patents. We then examine
other pertinent characteristics of the researchers, such as their tenured status, gender and
scientific board membership, to gain a complete holistic understanding of their
interactions with industry. The essential aim of our research at this point, is to profile the
researchers according to their Commercial Activity level.
The general survey done, we then focus on just the faculty members in the Biology
department, where we attempt to tackle the more difficult question of the intent of the
researchers, via a novel way of examining publication data. This would then allow us to
profile researchers according to their Commercial Potential level.
This quantitative analysis is the repeated with Singapore's faculty members as the
sample, before benchmarking Singapore against MIT.
Our final data set includes information about 776 patents and 5,259 journal articles
assigned to the sample faculty. We also explored 102 patents held by researchers in
Singapore. The patent data was collected from the Delphion Research database5 and the
United States Patent and Trademark Office (USPTO) website. 6 We conducted keyword
searches of the patents using the researcher names, irregardless of the assignee. Where
ambiguity arise, we cross check with the researchers' listed patents on his curriculum
vitae. The patents collected are only United States patents awarded by the USPTO and
represents all patents awarded to the researchers, as of 9th of January, 2004.7 Figure 2
shows a sample of our patent data,
5 www.delphion.com
6 www.uspto.gov
7 Patent issue dates as opposed to patent application dates are used in this thesis.
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Figure 2: Patent data
Publication data was collected from the Institute of Scientific Information's Science
Citation Index8 . We conducted key-word searches using the names of the researchers,
irregardless of assignee. Where ambiguity arise, we cross check with the curriculum
vitae of the researchers. Only full journal articles are used in our analysis. Figure 3
shows a sample of our publication data.
Swww.webofscience.com
20
Figure 3: Publications data
The results of our analysis are described in detail in Chapter 4.
4 Analysis of Results
4.1 MIT Results
4.1.1
Table
Patents
1 summarizes the descriptive statistics for the MIT faculty members.
Total number of faculty members 143
Total number of unique patents 776
Number of faculty members with at least 1 patent 76 (53.1%)
Number of faculty members with at least 5 patents 45 (31.5%)
Number of faculty members with at least 1 patent/year 16 (11.2%)
Table 1: Descriptive statistics for MIT faculty
Figure 4 shows the distribution of the patents among the faculty members. We see that
the patent ownership is strongly skewed towards a minority of researchers. Only about
11% of the faculty members have at least 1 patent/year. 47% of all the faculty members
do not hold a single patent.9 On further analysis, it would be worthwhile to note that the
top 10% (14) of the faculty members hold more than 57% (444) of the total number of
patents. This is clearly seen in Figure 4.
9 This is based on what have been able to identify from the USPTO and Delphion databases and it is
accurate barring no mistakes in spelling of the patent holders' names in the databases or incomplete records
in the databases.
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Figure 4: Patents versus Faculty Member
Total Patents
U Rest of Faculty
ITop 10% Faculty
Figure 5: Top 10% of faculty members hold 57% of total number of patents.
The patent rate also shows that the majority of the patenting work has been performed by
a minority of faculty members.
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Figure 6: Patent Rate versus Faculty Member
This data is representative of the researchers' entire career to date, hence older faculty
members would naturally be more heavily represented, due to their relatively longer
careers. To prevent unfairly discounting relatively junior faculty, we now concentrate on
patents that have been awarded only in the last 5 years (1999 to 2003) of our study.
Figure 7 shows the patent rate of the faculty members in this period of time.
Patents per Year versus Faculty Member
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Figure 7: Patent Rates versus Faculty Member
This gives us a partial understanding of how commercial applications related research is
conducted within the academic setting. However in our analysis, we also need to adjust
for the quality of the patents to obtain a more comprehensive picture. Much work has
already been done to investigate the patent-citation relationship, and we adjust the quality
of the patents based on seminal work done by Trajtenberg (1990) and Henderson (1998).
A widely cited patent has been shown to be an important contribution to technical
progress and to be of economic significance (Trajtenberg 1986). We use the measure of
Mean Forward Patent Citation to account for the relative importance of each patent,
adapted from Henderson's generality measure (Henderson, Jaffe and Trajtenberg, 1998).
Mean Forward Patent Citation = I# forward citations / I# patents
(1)
The higher the faculty member's Mean Forward Patent Citation, the more commercially
productive his research work is. Figure 8 shows the Mean Forward Patent Citation of the
researchers, for both their overall research career, and for the last 5 years.
Mean Forward Citation
* Mean Forward Citation (Overall)
I Mean Forward Citation (1999-2003)
20 40 60 80
Faculty Member
100 120 140 160
Figure 8: Mean Forward Patent Citation versus Faculty Member
Table 2 extends this current line of analysis by showing the correlation coefficients
between the patent rates, total patents and the Mean Forward Patent Citations, for both
the researcher's overall active career and the last 5 years. The analysis is conducted for
faculty members who have at least one patent.
Total Patents Mean Total Patents per Mean Forward
Patent per Year Forward Patents Year Patent Citation
s Patent (1999-2003) (1999-2003) (1999-2003)
Citation
Total Patents 1.00
Patents per Year 0.22 1.00
Mean Forward 0.83 0.07 1.00
Patent Citation
Total Patents 0.90 0.11 0.87 1.00
(1999-2003)
Patents per Year 0.90 0.11 0.87 1.00 1.00
(1999-2003)
Mean Forward 0.45 0.20 0.35 0.47 0.47 1.00
Patent Citation
(1999-2003)
Table 2: Correlation Matrix for Patents, Patent Rate and Mean Forward Patent Citation
The results are interesting. The overall patent rate and the patent rate for the last 5 years
show a strong correlation (0.90). This suggests that researchers who are active in
commercially related research tend to be active throughout their careers.
We also see that the Mean Forward Patent Citation shows little correlation to the actual
patent rate, both for the overall career (0.07) and for the last 5 years (0.47). This is an
important result. This suggests that quality adjustment for the patents are critical in
determining who are the researcher who have been most active in translating academic
research into useful technology. As such, Mean Forward Patent Citation will form the
key measure for our subsequent analysis.
We note that the Mean Forward Patent Citation for the overall career is not highly
correlated to the Mean Forward Patent Citation for the last 5 years. This suggests that
there may exist a considerable lag between the development of a technology, and the end
of its usefulness in the market. Indeed literature suggests even after 25 years, forward
citations do not tail off for the average patent. (see Jaffe and Trajtenberg, 2002, Chapter
13) Hence for our subsequent analysis, we will explore data for the last 5 years only, so
that junior researchers would not be discriminated against in our analysis.
4.1.2 Profiling the Researchers
The collective results thus far provide us with clear information as to who has been the
most active in commercial related research. It is clear here that the majority of
commercial related work is done by only a minority of the researchers. This allows us to
capture the Commercial Activity dimension, of the researchers. However, while we can
identify the most active researchers from our productivity measures, we still want to
know if these "star" researchers can be distinguished by a set of characteristics.
Towards this end, we conduct further statistical analysis. We first separate the faculty
members into different bins, based on their Mean Forward Patent Citation for the period
1999-2003. We chose a set of threshold values to separate the researchers into 3 groups.
Group Mean Forward Patent Citation (1999-2003)
Low 0
Medium 0<x<1
High x>1
Where x is the Mean Forward Patent Citation (1999-2003)
Table 3: Faculty groups
We also compile a set of descriptive statistics of these researchers. These are:
* Tenured status
* Gender
* Scientific Advisory Board membership in commercial firms
The research idea is to understand if Mean Forward Patent Citation is related to these
variables. We assign a value of 1 or 0 for the tenured status, gender and scientific
advisory board membership. This is summarized in Table 4.
Male 1
Female 0
Tenured 1
Non Tenured 0
Scientific Advisory Board (SAB) membership 1
Scientific Advisory Board (SAB) non-membership 0
Table 4: Variables values
We then run a series of T-tests for these variables, between each group of researchers.
The aim is to find if there are any variables that are statistically significant, with regards
to the researchers' variations in Mean Forward Patent Citations. The key assumption is
that the underlying distribution of the variables is Poisson and random. The results of the
tests are summarized in Table 5, 6 and 7.
Gender: Ho: mean(a) - mean(b) = 0
Low-High t= -0.1596, P= 0.8734
Medium - High t= 1.8406, P = 0.0724
Low - Medium t= -1.9508, P = 0.0536
Table 5: T-test for Gender
Tenured: Ho : mean(a) - mean(b) = 0
Low - High t=-2.3845, P = 0.0186
Medium - High t= -1.1216, P = 0.2681
Low - Medium t= -0.8752, P= 0.3834
Table 6: T-test for Tenured Status
Tenured: Ho: mean(a) - mean(b) = 0
Low - High t= -1.3068, P = 0.1937
Medium - High t= 0.5381, P = 0.5932
Low - Medium t= -1.7975, P= 0.0750
Table 7: T-test for Scientific Advisory Board Membership
The results are decidedly ambiguous. None of the comparisons for Gender, suggest that
the mean Gender variable is different across the comparison groups. For Tenured Status,
only in one comparison group (Low-High) is the P value sufficiently low to reject the
null hypothesis. This may be significant. It suggests that the Tenured status of the
faculty may interact with the extent of the participation of the faculty members in
commercially related research. For the Scientific Board Membership, comparisons
between the Low and High groups, and the Low and Medium groups both suggest there
is some statistical evidence, that the mean SAB membership variable is different. We
investigate this further by regressing Mean Forward Patent Citation as a dependent
variable against tenured status, gender and SAB membership, as independent variables.
We adopt a log-linear model with a underlying Poisson statistical distribution. l0  We
model the equation as:
Ln(Fij) = p + )iA + jB + kijAB (2)
Ln(Fij) = is the log of the expected cell frequency of the cases for cell ij in the
contingency table.
p, = is the overall mean of the natural log of the expected frequencies
A= terms each represent "effects" which the variables have on the cell frequencies
10 The above model is considered a Saturated Model because it includes all possible oneway and two-way
effects. Given that the saturated model has the same amount of cells in the contingency table as it does
effects, the expected cell frequencies will always exactly match the observed frequencies, with no degrees
of freedom remaining (Knoke and Burke, 1980).
A and B = the variables (Mean Forward Patent Citation, Tenured status, Gender and
Scientific Advisory Board membership)
i andj = refer to the categories within the variables
Therefore:
XiA = the main effect for variable A
jB = the main effect for variable B
AijAB = the interaction effect for variables A and B
Low group is assigned value of 0, Medium is assigned 1, while High is assigned 2. The
null hypothesis is that there are no interactions among the variables. Refer to Table 8 for
the detailed regression results.
Dependent variable Mean Forward Patent
Citation (1999-2003)
No. of observations 143
Tenured Status 0.98 (0.40) *
Gender 0.08 (0.35)
Scientific Advisory Board 0.35 (0.26)
Membership
Intercept -1.64 (0.47)
Log Likelihood 0.13
*p<0.05; **p<0.01
Table 8: Mean Forward Patent Citation as a function of researcher characteristics. Saturated model.
Standard errors in parentheses.
The P values for Tenured Status (0.01), Gender (0.538) and SAB membership (0.18)
suggest that Gender and SAB membership is not a significant factor in determining the
Mean Forward Patent Citation, but the Tenured Status is. This is potentially an important
result. However, we run into the risk of misrepresenting the causality direction -- that is
the Mean Forward Patent Citation or the commercial productivity of the faculty
members, could be influencing the Tenured Status of the researchers, instead of the other
way round. Nevertheless, the results suggest there is interaction between these variables.
Collectively, the results suggest that the researchers are highly heterogeneous in their
characteristics, and no clear set of characteristics appear to be uniquely associated with
high patenting activities. The results do suggest that the tenured status could potentially
be a factor in determining the commercial activities of a researcher. In the next section,
we pry into the publication data of the researchers, and develop a set of statistical
measures to compare them, to understand the relationship between patenting and
publishing behaviors.
4.2 Biology Department
In this section, we introduce a novel way of examining publication data. The sample
researchers are the faculty on Biology Department, a total of 61 faculty members. We
choose to focus on a single department here because publication rates tend to differ
substantially for different fields of research. Hence it might not be wholly fair to
compare across departments.
Figure 9 shows the scatter plot of Mean Forward Patent Citation versus Publication Rate,
for the period 1999 to 200311 , where the unit of observation is the faculty member. No
clear relationship is evident.
" The publication data includes articles written in January 2004.
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Figure 9: Publications per Year versus Mean Forward Patent Citation (1999-2003)
We next check for the correlation between total publications and total number of patents.
The correlation is low, only 0.43. This suggests that patent activity does not appear to be
significantly related to publishing activity.
Our aim now is to examine the publication stock of each researcher, and determine its
kind. We broadly define journals to belong to three categories: basic research, applied
research and medical research. Then we categorize each published article according to
its source journal. For example, an article published in Nature Biotechnology is
categorized as an applied research article, while an article published in Science is
categorized as a basic research article.
This classification could potentially be too sweeping. Moreover, some areas of research
cannot be clearly defined as applied or basic, but rather is at the boundary. 12 However,
12 There is much debate with regards to the definition of basic and applied research. However, Basic
Research (also called fundamental or pure research) is generally defined to have as s its primary objective
certain journals such as Nature Biotechnology and Protein Technology are clearly
focused on applied research. We take a cautious approach here, by only defining a
journal as Applied when it is completely unambiguous; otherwise the journal is labeled as
Basic.
We establish the ratio of applied research articles to basic research articles for each
researcher, and compare them to their respective Mean Forward Patent Citation for
patents. The assumption here is that faculty members with a higher proportion of
published articles that are applied in nature, have engaged in research that are more likely
to translated into market innovations. Thus by examining their publication stock for the
ratio of applied to basic research articles, we are also uncovering the respective research
areas and focuses of each faculty member.
We estimate specifications of the general form
Mean Forward Patent Citation (patents) = flo + P/32 Ratio of Applied to Basic Research
Publications +6xit + c (3)
Where xit is a vector of control variables and e is the error term.
Refer to Table 9 for the full regression results. We control for the tenured status, gender,
total number of basic research articles, total number of applied research articles and the
Scientific Advisory Board membership of the faculty members.
the advancement of knowledge and the theoretical understanding of the relations among variables.
Applied Research on the other hand is done to solve specific, practical questions; its primary aim is not to
gain knowledge for its own sake. It can be exploratory but often it is not. It is almost always done on the
basis of basic research. For more on the distinction between basic and applied research, refer to Holton and
Sonnert (1999), and Branscomb (1999).
Dependent variable
No. of observations
Ratio of applied research to
basic research articles
(1999-2003)
Number of basic research
articles (1999-2003)
Number of applied research
articles (1999-2003)
Tenured Status
Gender
Scientific Advisory Board
Membership
Intercept
R 2
Adjusted R2
Mean Forward Patent
Citation
61
1.37 (0.44) **
0.10 (0.15)
0.14
0.13
Mean Forward Patent
Citation
61
2.02 (0.74) **
0.01 (0.01)
-0.06 (0.05)
0.05 (0.32)
0.25 (0.35)
-0.34 (0.31)
-0.02 (0.38)
0.16
0.10
*p<0.05 ; **p<0.01
Table 9: Mean Forward Patent Citation as a function of publication behavior. Fixed effect models.
Standard errors in parentheses.
The results are very interesting. The results suggest that the Mean Forward Patent
Citation is positively related to the ratio of applied to basic research publications.
Even after controlling for the control variables, the results indicate that the Mean Forward
Patent Citation is positively related to the ratio of applied research articles to basic
research articles. Our results suggest that the area of research (as determined from a
broad distinction between basic and applied research articles) strongly predicts a
researcher's patenting activity and commercial productivity, as measured by his Mean
Forward Patent Citation. In fact the effect is enhanced after controlling for the variables
(the coefficient increases from 1.37 to 2.02).
This set of results captures the missing dimension that previous studies have typically
failed to address. It suggests that the level of useful Commercial Activity of a researcher
depends strongly on the level of Commercial Opportunity that the researcher affords
himself. The more inclined towards applied science research the research is, the more
likely he is active in commercial related work.
Lastly, we turn to the difficult question of the degree to which patenting acts as a
substitute or complement to the process of conducting fundamental research. In
commercial settings, basic, or "fundamental", research is often considered a substitute for
more applied work (Cockburn, Henderson and Stern, 2001). Several observers have
worried that a similar dynamic may be at work within universities, and that an increasing
focus on the commercial implications of university research may skew university faculty
away from the more fundamental work that universities were originally created to
produce.
To this end, we examine the relationship between the number of basic research articles,
applied research articles, ratio of applied research to basic research articles, as well as the
overall number of publications. Table 10 shows the correlation coefficients between
these variables.
# basic research # applied Ratio of applied Number of Mean
articles (1999- research articles research to articles Forward
2003) (1999-2003) basic research (1999-2003) Patent
articles (1999- Citation
2003) (1999-2003)
# basic 1.00
research
articles (1999-
2003)
# applied 0.38 1.00
research
articles
(1999-2003)
Ratio of -0.16 0.64 1.00
applied
research to
basic research
articles (1999-
2003)
Number of 0.94 0.55 0.00 1.00
articles (1999-
2003)
Mean Forward -0.11 0.12 0.38 -0.08 1.00
Patent Citation
(1999-2003)
*p<0.05 ; **p<0.01
Table 10: Correlation Matrix for number of basic research articles, number of applied research
articles, ratio of applied research to basic research articles, total number of articles and Mean
Forward Patent Citation
The results suggest there is a very slight tradeoff between the number of basic research
articles and the ratio of applied research to basic research articles. This is supported by
the slight tradeoff we see between the Mean Forward Patent Citation (1999-2003) and the
number of basic research articles. However, based on these results, there appears to be
little correlation between the ratio and the total number of articles for each researcher. In
other words, the publication output does not appear to be affected by the choice of the
research agenda.
We extend this line of analysis by examining the relationship between the total patent
stock of the researcher from 1999 to 2003, and his total publication stock for that
corresponding period. Again, we estimate specifications of the general form
Total Number of Patents = f3o + /#2 Total Number of Publications +&it + e (4)
Where xit is a vector of control variables and e is the error term.
Refer to Table 11 for the full regression results. We control for the tenured status,
gender, total number of basic research articles, total number of applied research articles
and the Scientific Advisory Board membership of the faculty members.
Dependent # of # of # of # of # of
variable Publications Publications Publications Publications Publications
(1999-2003) (1999-2003) (1999-2003) (1999-2003) (1999-2003)
# 61 61 61 61 61
observations
# of patents 1.97 (0.63) ** 1.98 (0.63) ** 1.68 (0.62) ** 1.39 (0.62) * 0.50 (0.67)
(1999-2003)
Ratio of -1.15 (7.18) -4.79 (7.09) -5.70 (6.91) -7.81 (6.56)
basic
research to
applied
research
articles
(1999-2003)
Tenured 11.86 (5.11) * 12.70 (4.98) * 14.49 (4.74) **
Status
Gender 10.78 (5.11) * 6.64 (5.04)
Scientific 14.13 (4.02) **
Advisory
Board
Membership
Intercept 21.27 (2.46) 21.48 (2.49) 13.78 (4.27) 5.40 (5.75) 4.68 (5.43)
R2  0.14 0.14 0.22 0.28 0.37
Adjusted R2  0.13 0.11 0.18 0.22 0.31
*p<0.05; **p<0.01
Table 11: Number of publications as a function of number of patents. Fixed effect models. Standard
errors in parentheses.
The results are very interesting. The total number of publications is statistically
positively correlated to the total number of patents, without controlling for the control
variables. As we include the tenured status, gender and the ratio of applied to basic
research articles, as control variables, the effect is reduced but is still significant.
However, once SAB membership is added, the effect of total number of patents is no
longer significant. SAB membership, together with the tenured status is the most
significant variables. It is important to note the R2 values have increased consistently as
we add the control variables, indicating a closer fit of the data points to our proposed
model.
The results suggest there is considerable interaction between the SAB membership of the
researcher and his total publication. This is understandable, since commercial firms are
likely to want to only hire prominent and widely publishing faculty members as their
scientific advisors. However, we want to investigate this further. We first eliminate the
effect of tenured status on the regression, by only examining tenured faculty members.
Again, we estimate specifications of the general form
Total Number of Patents = fo + f2 Total Number of Publications +6xit + e (5)
Table 12 summarizes the results. The control variables are the ratio of applied to basic
research articles, gender and SAB membership of the faculty members.
Dependent Variable # of Publications # of Publications
(1999-2003) (1999-2003)
# of Observations 46 46
# of Patents 1.70 (0.69) * 0.33 (0.73)
Ratio of applied to basic -8.90 (7.14)
research articles (1999-
2003)
Gender 6.89 (6.19)
Scientific Advisory Board 18.62 (6.26) **
Membership
Intercept 24.52 (3.08) 18.25 (5.23)
R 0.12 0.34
Adjusted R2  0.10 0.27
*p<0.05; **p<0.01
Table 12: Number of publications as a function of number of patents, for tenured faculty only. Fixed
effect models. Standard errors in parentheses.
After controlling for the control variables, only the SAB membership variable is
significant. This is a highly significant result. Together with the earlier, more general
regression, it suggests that after controlling for the characteristics of the faculty members,
the patenting and publishing behaviors of the faculty members bear little relation to each
other. These series of results echo that of Henderson and Agrawal's. (Henderson, R and
Agrawal, A, 2001)
On the other hand, our results also suggest that the SAB membership and tenured status
of the faculty members interact significantly with the publishing behavior of the faculty
members. This is expected, as high rates of publishing should help a researcher's cause
for tenureship, while commercial firms would naturally seek out researchers who are
prolific and prominent.
To achieve a complete understanding, we now test the reverse relationship and estimate
the effect of publication output on patent output. Table 13 shows the key statistics.
Dependent # of Patents # of Patents # of Patents # of Patents # of Patents
variable (1999-2003) (1999-2003) (1999-2003) (1999-2003) (1999-2003)
# 61 61 61 61 61
observations
# of 0.07 (0.02) ** 0.07 (0.02) ** 0.07 (0.02) ** 0.06 (0.03) * 0.02 (0.03)
publications
(1999-2003)
Ratio of basic 0.65 (1.37) 0.43 (1.43) 0.30 (1.43) -0.41 (1.34)
research to
applied
research
articles (1999-
2003)
Tenured 0.69 (1.07) 0.85 (1.08) 1.52(1.01)
Status
Gender 1.05 (1.09) 0.23 (1.03)
Scientific 3.28(0.99) **
Advisory
Board
Membership
Intercept 0.06 (0.71) -0.07 (0.76) -0.41 (0.93) -1.12 (1.19) -1.94 (1.09)
R2  0.14 0.15 0.15 0.17 0.31
Adjusted R2  0.13 0.12 0.11 0.11 0.24
*p<0.05; **p<0.01
Table 13: Number of patents as a function of number of publications. Fixed effect models. Standard
errors in parentheses.
The results are very similar. Once we control for SAB membership, the number of
publications is no longer significant. This reinforces our results that the publishing
behavior and patenting behavior are not correlated.
The collective results shed new light on the interface between academic research and
commercial applications. While previous studies (see Henderson and Agrawal, 2001)
have suggested that neither patenting nor publishing is generally the motivation for
selecting a particular research agenda, our quantitative method of analyzing the kind of
publications the researcher publishes, suggests that the research agenda and material
directly impacts the patenting and commercial activity of the researcher. On the other
hand, the choice of the research agenda does not significantly impact the total publication
output of the researchers.
4.3 Singapore
We now turn finally to our analysis on Singapore. It is worthwhile to bear in mind that
Singapore is a relatively newcomer into biomedical sciences research. Both the
researchers as well as the research institutes, are very new relative to MIT. 13
We will retain the same measures we have used throughout this thesis. The main
instrument of measure, will be the quality adjusted Mean Forward Patent Citation of the
researchers, for the last five years (1999-2003). Table 10 summarizes the key statistics
for Singapore.
Total number of faculty members 145
Total number of unique patents 102
Number of faculty members with at least 1 patent 13 (9.0%)
Number of faculty members with at least 5 patents 5 (3.4%)
Table 14: Descriptive statistics for Singapore faculty
13 The oldest research institute in our studies here is the Institute of Molecular and Cell Biology which was
set up only in 1987.
Figure 10 shows the scatter plot of the number of patents held by the researchers, for both
their overall careers and for the last five years.
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Figure 10: Number of Patents versus Faculty Member
It is clear from the scatter plot that the majority of the researchers do not patent or have
yet to patent. The latter is more likely to be the case, bearing in mind the youth of the
research institutes. The statistics tell a similar story. Only 9% of the faculty members
hold any patents, and only 8% of the faculty members have had at least one awarded
patent in last five years. It is worthwhile to note that the top 2 researchers in terms of
individual number of patents, are both recently hired foreign scientists, one a Nobel
laureate and the other, a tenured Chemical Engineering Professor in MIT. 14
14 They are Sydney Brenner of the Salk Institute and Jackie Ying of MIT. Both started their collaborations
with Singapore in 2002. Jackie Ying is also the Executive Director of the Institute of Bioengineering and
Nanotechnology.
We adjust for the quality of the patents via the established measure that we have
developed in this thesis, the Mean Forward Patent Citation. The overall statistics remain
the same. A large majority of the researchers are not commercially active yet.
Mean Forward Citation
* Mean Forward Citation
' Mean Forward Citation (last 5 years)
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Figure 11: Mean Forward Patent Citation versus Faculty Member
Chapter 5 Conclusion
This thesis has taken a broad survey of the commercial activities of the researchers in
MIT and Singapore. In this Chapter, we will draw upon the results we have obtained
from our research, and derive possible policy recommendations for the developing
biomedical cluster in Singapore
Our results suggest that Singapore has some way to go before it can emulate MIT's level
of commercial activity. The proportion of scientists that are commercially active in MIT
far exceeds that in Singapore. This is understandable, given the disparity in the age of the
respective institutions.
Our results also suggest that the level commercial activity of the researchers in MIT's
Biology department are highly correlated to the choice of research material. Researchers
with a stronger bent towards applied research are likely to be commercially more active
as well.
This is important for Singapore as it seeks to develop it own biomedical cluster. The role
of academic research is well acknowledged already, as can be seen from the massive
expansion of research facilities, and investment in recruiting scientists from all over the
world. 15 However this may not be enough. It is important to note that Singapore can
potentially do better by recruiting and fostering scientists with greater focus on applied
research, as this is likely to yield greater commercial returns to Singapore.
This is not to discount the importance that basic science research plays. Basic science
research is key to building the scientific knowledge foundation upon which future
research may build upon. However, our results do suggest that Singapore may need to
increase the level of applied science research in the research institutes, as a proportion of
the total research conducted, to emulate MIT's role in the development of the Cambridge
biomedical cluster. Moreover, this is supported by our findings that the overall
15 Singapore has invested committed US$1.7 billion towards biotechnology investments, while constructing
a new 200 hectare industrial park for the life sciences, called the Biopolis.
publishing rates of the researchers are not correlated to the relative level of applied
science research conducted.
Clearly much remains to be done. We need to conduct a much finer grained analysis of
the different channels different firms access information. It is important to realize that
patents are not the only channel for university research knowledge to be accessed and
utilized by commercial firms. Indeed, some studies (see Branstetter, 2000; Cohen et al,
1998) have suggested that even within MIT itself, patents may represent only a relatively
small channel for the transfer of knowledge out of the university.
In addition, we need to focus on the effect of time on the commercial activity of faculty
members. The commercial activity of faculty members can change along their careers,
and as our results suggest, the tenured status of the researchers appear to be correlated
with the level of commercial activity. Such more in depth studies on the heterogeneity of
faculty behavior and characteristics are key to our further understanding. We are hopeful
that the data presented in this thesis will allow us to make progress on understanding
these.
Appendix
STATA Regression Results
glm mean sab tenured gender, family(poisson)
Iteration 0: log likelihood = -140.94881
Iteration 1: log likelihood = -138.05709
Iteration 2: log likelihood= -138.0566
Iteration 3: log likelihood= -138.0566
Generalized linear models No. of obs = 143
Optimization :ML: Newton-Raphson Residual df = 139
Scale parameter = 1
Deviance = 166.315734 (1/df) Deviance = 1.196516
Pearson = 172.2148852 (1/df) Pearson = 1.238956
Variance function: V(u) = u [Poisson]
Link function : g(u) = ln(u) [Log]
Standard errors : OIM
Log likelihood = -138.0565988 AIC = 1.986806
BIC = -523.5196696
regress mean ratio
Source I SS df MS Number of obs = 61
-------------- +-------------------------- F( 1, 59)= 9.65
Model 1 10.5259436 1 10.5259436 Prob > F = 0.0029
Residual 1 64.3378429 59 1.09047191 R-squared = 0.1406
-------------------------------------- Adj R-squared = 0.1260
Total 1 74.8637865 60 1.24772977 Root MSE = 1.0443
mean I Coef. Std. Err. t P>jlt [95% Conf. Interval]
----------------------------------- ---------------------
ratio I 1.369093 .4406661 3.11 0.003 .487322 2.250864
_cons .1008129 .157527 0.64 0.525 -.2143979 .4160237
50
regress mean ratio tenured gender sab
Source I SS df MS Number of obs = 61
-------------- + -------------------------- F( 4, 56)= 2.68
Model 12.0439919 4 3.01099797 Prob > F = 0.0405
Residuall 62.8197946 56 1.12178205 R-squared = 0.1609
---------------------------------------- Adj R-squared = 0.1009
Total j 74.8637865 60 1.24772977 Root MSE = 1.0591
mean Coef. Std. Err. t P>jtj [95% Conf. Interval]
----------------------------------- --------------------
ratio 1.392561 .462174 3.01 0.004 .4667157 2.318407
tenured I .049183 .3236492 0.15 0.880 -.5991643 .6975303
genderl .2482922 .355617 0.70 0.488 -.4640943 .9606787
sabl -.3443543 .3116033 -1.11 0.274 -.9685707 .2798621
cons I -.0231864 .3810527 -0.06 0.952 -.7865268 .7401539
regress total patent
Source I  SS df MS I
--------- +-----------------------------
Model I 2827.63086 1 2827.63086
lumber of obs =
F( 1, 59)=
Prob > F
61
9.97
= 0.0025
Residual I 16738.3691 59 283.701172 R-squared = 0.1445
-------------- +------------------------- Adj R-squared = 0.1300
Total I 19566 60 326.1 Root MSE = 16.843
total I Coef. Std. Err. t P>|tj [95% Conf. Interval]
----------------------------------- ---------------------
patent 1.975982 .6258962 3.16 0.003 .7235671 3.228398
-cons 21.27479 2.458285 8.65 0.000 16.35577 26.1938
regress total patent ratio
Source I SS df MS Number of obs = 61
-------------- + -------------------------- F( 2, 58)= 4.91
Model 1 2835.08172 2 1417.54086 Prob > F = 0.0107
Residual 1 16730.9183 58 288.464108 R-squared = 0.1449
-------------- +-------------------------- Adj R-squared = 0.1154
Total I 19566 60 326.1 Root MSE = 16.984
total I Coef. Std. Err. t P>|tl [95% Conf. Interval]
------------------------+---- ----------------------
patent 1 1.981943 .632217 3.13 0.003 .7164231 3.247463
ratio -1.153862 7.179543 -0.16 0.873 -15.52528 13.21755
cons 21.48166 2.793106 7.69 0.000 15.89065 27.07266
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